Risk assessment of global COVID-19 pandemic in January 2022
Disease Surveillance
; 37(2):154-158, 2022.
Article
in Chinese
| GIM | ID: covidwho-1855883
human diseases; epidemiology; viral diseases; coronavirus disease 2019; risk factors; epidemics; pandemics; risk assessment; trends; man; Severe acute respiratory syndrome coronavirus 2; China; Afghanistan; Argentina; Australia; Bangladesh; Brazil; Canada; Central Asia; England; France; Germany; India; Iran; Italy; Japan; Kyrgyzstan; Lebanon; Mexico; Mongolia; Pakistan; Philippines; Russia; Spain; Tajikistan; Thailand; Tunisia; Uk; USA; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Least Developed Countries; low Human Development Index countries; low income countries; West Asia; Latin America; America; South America; very high Human Development Index countries; Australasia; Oceania; Commonwealth of Nations; high income countries; OECD Countries; lower-middle income countries; medium Human Development Index countries; South Asia; Community of Portuguese Language Countries; North America; Great Britain; British Isles; Western Europe; Europe; European Union Countries; Mediterranean Region; Middle East; Southern Europe; ASEAN Countries; South East Asia; Francophone Africa; Africa; Maghreb; North Africa; SARS-CoV-2; viral infections; People's Republic of China; Kirgizia; Russian Federation; Tadzhikistan; Britain; United Kingdom; United States of America
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Type of study:
Prognostic study
Language:
Chinese
Journal:
Disease Surveillance
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS